Advanced Oncotherapy shares soar as its acquires CERN spinoff

more »

AIM quoted micro-cap life science firm Advanced Oncotherapy (LON:AVO) soared after it announced a deal to acquire ADAM, a spin-off from CERN which is developing particle accelerators to treat cancer. While CERN is spending billions researching the ... See all stories on this topic »

Proactive Investors UK

via Google Alerts: News from CERN